Citius Pharmaceuticals (CTXR) Corporate Presentation from NobleCon18
News and Market Data on Citius Pharmaceuticals
NobleCon 18 Complete Rebroadcast
Take it to the next level. It doesn’t cost a penny.
Join the Channelchek Investor Community. Your name, email, zip, and investor type is all it takes to open the door to research reports, favorites tracking, and virtual and in-person roadshows / conferences. Even exclusive investment opps.
‌
Share
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
5/17/2024
Health
Release – GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a definitive securities purchase agreement...
‌
5/17/2024
Health
Schwazze (SHWZ) – In for the Long Haul
1Q24 Results. Revenue of $41.6 million was up 4% y-o-y, driven by new store growth. Gross margin declined to 43.1% from 54.6% due to pricing pressure in New Mexico and a...
‌
5/17/2024
Financial Services
Bit Digital (BTBT) – AI Showing its Impact
AI Adding to Growth. Total revenue for the first quarter was $30.3 million compared to $8.3 million in the prior year. This surpassed our $23.5 million estimate, as a higher bitcoin...
‌
5/17/2024
Energy
Crescent Shells Out $2.1 Billion for Massive Eagle Ford Upgrade
In a transformative transaction for the U.S. shale industry, Crescent Energy Company has agreed to acquire rival Eagle Ford producer SilverBow Resources in an all-stock deal valued at $2.1 billion....
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.
